These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1485939)

  • 1. Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics.
    Kesäniemi YA; Lilja M; Kervinen K; Rantala A
    Ann Med; 1992 Dec; 24(6):461-4. PubMed ID: 1485939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial dyslipidaemic hypertension and other multiple metabolic syndromes.
    Williams RR; Hopkins PN; Hunt SC; Schumacher MC; Elbein SC; Wilson DE; Stults BM; Wu LL; Hasstedt SJ; Lalouel JM
    Ann Med; 1992 Dec; 24(6):469-75. PubMed ID: 1485941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus.
    Li JK; Ng MC; So WY; Chiu CK; Ozaki R; Tong PC; Cockram CS; Chan JC
    Diabetes Metab Res Rev; 2006; 22(1):46-52. PubMed ID: 16021651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reaven's metabolic syndrome X in the families of individuals with premature cerebrovascular attacks].
    Vaverková H; Ficker L; Vlachová I; Chudácková J; Novotný D; Budíková M
    Vnitr Lek; 1993 Aug; 39(8):745-54. PubMed ID: 8212622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive examinations of phenotypically healthy offspring of patients with a metabolic syndrome].
    Kopf D; Lehnert H
    Dtsch Med Wochenschr; 2001 Mar; 126(9):235-40. PubMed ID: 11256038
    [No Abstract]   [Full Text] [Related]  

  • 6. The dysmetabolic syndrome.
    Groop L; Orho-Melander M
    J Intern Med; 2001 Aug; 250(2):105-20. PubMed ID: 11489060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
    Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
    Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic aspects of diabetes and its cardiovascular complications: contribution of genetics to risk assessment and clinical management.
    St-Pierre J; Vohl MC; Després JP; Gaudet D; Poirier P
    Can J Cardiol; 2005 Feb; 21(2):199-209. PubMed ID: 15729423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome.
    Lee SC; Pu YB; Thomas GN; Lee ZS; Tomlinson B; Cockram CS; Critchley JA; Chan JC
    Metabolism; 2000 Aug; 49(8):1021-4. PubMed ID: 10954020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic predisposition for multiple metabolic syndrome. Part 1. Diabetes mellitus type 2--incidence and prevalence].
    Sobra J
    Cas Lek Cesk; 1999 Jan; 138(1):6-11. PubMed ID: 10953428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dyslipidemia and hyperinsulinemia in normoglycemic-obese relatives of patients with non-insulin dependent diabetes mellitus].
    Florez H; Valbuena H; Ryder E; Rincón E; Campos G; Castillo S; González J; Fernández V; Raleigh X; Gómez ME
    Invest Clin; 1995 Sep; 36(3):131-47. PubMed ID: 7548306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].
    Benítez R; Sir-Petermann T; Palomino A; Angel B; Maliqueo M; Pérez F; Calvillán M
    Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic syndrome and fatal quartet].
    Standl E
    Internist (Berl); 1996 Jul; 37(7):698-704. PubMed ID: 8766263
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPY L7P polymorphism and metabolic diseases.
    Pesonen U
    Regul Pept; 2008 Aug; 149(1-3):51-5. PubMed ID: 18499283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes.
    Thomas GN; Tomlinson B; Chan JC; Sanderson JE; Cockram CS; Critchley JA
    Diabetes Care; 2001 Feb; 24(2):356-61. PubMed ID: 11213892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic Disorders.
    Allu PKR; Kiranmayi M; Mukherjee SD; Chirasani VR; Garg R; Vishnuprabu D; Ravi S; Subramanian L; Sahu BS; Iyer DR; Maghajothi S; Sharma S; Ravi MS; Khullar M; Munirajan AK; Gayen JR; Senapati S; Mullasari AS; Mohan V; Radha V; Naga Prasad SV; Mahapatra NR
    Diabetes; 2022 Mar; 71(3):538-553. PubMed ID: 34862200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.